Calif. and SHANGHAI, Aug. 10, 2026 /PRNewswire/ — Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first tranche exclusively, and a prominent strategic investor led a subsequent tranche, with participation from HighLight Capital (HLC) and follow-on investment from existing shareholders including MPCi and…
